Neuroendocrine Effects of Hypericum Extract WS 5570
in 12 Healthy Male Volunteers

In the present study, the effects of acute p. o. administration of placebo at 300 mg and 600 mg of WS 5570 Hypericum perforatum extract on cortisol (COR), growth hormone (GH) and prolactin (PRL) secretion were examined in twelve physically and mentally healthy subjects. WS 5570 is a hyperforin containing extract of St. John's Wort which has been proven effective in mild to moderate depression. After inserting an i. V. catheter, blood samples were drawn one hour prior to the administration of WS 5570 or placebo, at the time of application and up to five hours after application in 30-minute intervals. Plasma concentrations of COR, GH, and PRL were determined in each blood sample by double-antibody RIA methods. No PRL stimulation could be observed after placebo or after WS 5570 (300, 600 mg). A small but statistically significant elevation in GH AUC values occurred after 300 mg of WS 5570. After 600 mg of WS 5570, a clear-cut COR stimulation was observed, occurring from 30 up to 90 minutes after the application. In this period of time (from t = 30 min to t = 90 min), the mean COR concentrations were significantly higher after 600 mg of WS 5570 compared to placebo. 300 mg of WS 5570 did not show any effects on COR secretion. We propose that the Hypericum extract WS 5570 is able to influence central neurotransmitters, thereby causing COR stimulation in a dose-dependent manner.

References

• 1 Biber A, Fischer H, Römer A, Chatterjee S S. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 36-43
• 2 Brockmöller J, Reum T, Bauer S, Kerb R, Hübner W -H, Roots I. Hypericin and pseudohypericin - pharmacokinetics and effects on photosensitivity in humans.  Pharmacopsychiatry. 1997;  30 (Suppl.) S 94 - S 101
• 3 Butterweck V, Nahrstedt A, Winterhoff H. Effects of hypericum perforatum extract and isolated constituents on neurotransmitter concentrations and endocrine parameters.  Ann Congress Soc Med Plant Res. 1998;  J 29 53
• 4 Chatterjee S S, Nöldner M, Koch E, Erdelmeier C. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 7-15
• 5 Cowen P J, Anderson I M, Grahame Smith D G. Neuroendocrine effects of azapirones.  J Clin Psychopharmacology. 1990;  10 21S-25S
• 6 ESCOP - European Scientific Cooperative on Phytotherapy .Monographs on the medical use of plant drugs - Hyperici herba. Elburg ESCOP 1996
• 7 Franklin M, McGavin C, Reed A, Cowen P J. Effect of hypericum perforatum on salivary cortisol in healthy male volunteers.  J Psychopharmacol. 1999;  30 (Suppl. 2) A16
• 8 Franklin M, Chi J, McGavin C, Hockney R, Reed A, Campling G, Whale R WR, Cowen P J. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers.  Biol Psychiatry. 1999;  46 581-584
• 9 Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.  Prog Neuropsychopharmacol Biol Psychiatry. 1982;  6 277-295
• 10 Laakmann G, Schon H W, Wittmann M. Desipramine and growth hormone secretion.  Lancet. 1981;  2 996
• 11 Laakmann G. Psychopharmacoendocrinology and Depression Research. Berlin Heidelberg New York; Springer 1987
• 12 Laakmann G, Hinz A, Voderholzer U, Daffner C, Müller O A, Neuhauser H, Neulinger E. The influence of psychotropic drugs and releasing hormones on anterior pituitary hormone secretion in healthy subjects and depressed patients.  Pharmacopsychiatry. 1990a;  23 18-26
• 13 Laakmann G, Hinz A, Voderholzer U, Neuhauser H, Daffner C, Winkelmann M, Müller O A. Endocrine response to tricyclic antidepressants and peptides in depression with special regard to growth hormone secretion. In: Bunney, Hippius, Laakmann, Schmauß, (eds) Neuropsychopharmacology. Berlin Heidelberg; Springer 1990b: 563-577
• 14 Laakmann G, Schüle C, Baghai T, Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 54 - 59
• 15 Leong D A, Frawley L S. Neuroendocrine control of prolactin secretion.   Annu Rev Physiol. 1983;  45 109-127
• 16 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St. John's Wort for depression an overview and meta-analysis of randomized clinical trials.  BMJ. 1996;  313 253 - 258
• 17 Maisenbacher P, Kovar K A. Adhyperforin - a homologue of hyperforin from Hypericum perforatum.  Planta Med. 1992;  58 291 - 293
• 18 Müldner H, Zöllner M. Antidepressive Wirkung eines auf dem Wirkstoffkomplex Hypericin standardisierten Hypericum-Extraktes.  Arzneimittelforschung. 1984;  34 918 -920
• 19 Müller W E, Rolli M, Schäfer C, Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.  Pharmacopsychiatry. 1997;  30 (Suppl. 2) 102-107
• 20 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 16 - 21
• 21 Neary J T, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes.  Brain Research. 1999;  816 358 - 363
• 22 Neill J D. Neuroendocrine Regulation of Prolactin Secretion. In: Frontiers in Neuroendocrinology.  New York; Raven Press 1980 6: 129-155
• 23 Rolli M, Schäfer C, Müller W E. Effect of hypericum extract (LI 160) on neurotransmitter receptor binding and synaptosomal uptake systems.  Pharmacopsychiatry. 1995;  28 207
• 24 Simpson G M. Principles and techniques of applied mathematics. New York; Fredman and Wiley 1956
• 25 Singer A, Wonnemann M, Müller W E. Hyperforin, a major antidepressant constituent of St. John's wort, inhibits serotonin uptake by elevating free intracellular Na+1.  J Pharmacol Exp Ther. 1999;  290 1363 - 1368
• 26 Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H. Inhibition of monoamine oxidase by hypericin.  Planta Med. 1984;  50 272 - 274
• 27 Tuomisto J, Mannisto P. Neurotransmitter regulation of anterior pituitary hormones.  Am Soc Pharmacol Exp Ther. 1985;  37 249 - 311
• 28 Wagner H, Bladt S. Pharmaceutical quality of Hypericum extracts.  J Geriatr Psychiatry Neurol. 1994;  7 (Suppl. 1) 65-68
• 29 Wuttke W, Horowski R. Gonadal Steroids and Brain Function.  Exp Brain Res.. 1981;  3 182-199